Abstract
AimsTo study long-term, whole population ‘real-world’ clinical outcomes of ranibizumab therapy in treatment-naïve eyes for neovascular age-related macular degeneration.MethodsData collected prospectively from a single centre serving a defined population using...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
